Baird Downgrades Apellis Pharmaceuticals (APLS) to Neutral

March 31, 2026 11:51 AM

Baird analyst Colleen Kusy downgraded Apellis Pharmaceuticals (NASDAQ: APLS) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found